Guided Therapeutics Overview
Get informed when a big investor buys or sells
+ Follow14.20
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Guided Therapeutics (GTHP) currently reports a PEG ratio of 14.2. That is above the sector sector average of 9.98. Use the charts on this page to explore Guided Therapeutics's PEG ratio history and peer comparisons.
Guided Therapeutics's PEG ratio of 14.2 is higher than the its sector sector average of 9.98. That is roughly 42.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Guided Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 14.2, GTHP can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 14.2, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 9.98. From there, open related valuation or income-statement pages for Guided Therapeutics, and consider following GTHP for alerts when major investors trade the stock.
